Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Shareholders
View:
Post by Solid1 on Dec 23, 2023 5:27am

Shareholders

On marketscreener, the shareholder structure shows a position with over 91 million shares but no name... probably a mistake because such changes are actually notifiable
Comment by subaru1i on Dec 23, 2023 10:30am
Is there a date stamp on that position because yes, that large of a position is reportable but the holder is given a period of time of which to file the report.   So.....we can not eliminate the possibility of that large position existing without a date stamp of when such a large position existed.    I want to say that reporting has to be done within 5 to 10 days? 
Comment by alleyesonme on Dec 23, 2023 10:56am
Now that management has enriched their future with 30m options at an all time low valuation..no need for additional share based compensation..no need to withhold information like expanded partnerships with avicanna and SEDDS IP..I bet Brazilian authorization has already been granted..the story here is now finally, the share price increase with full backing and support will be unleashed.   ...more  
Comment by subaru1i on Dec 23, 2023 12:09pm
Agree, reading between the lines is not silent but rather screaming in your face.  Golden parachutes issued at $.06 and negative eps?  On the surface it makes no sense at all until you bring the bigger picture into clearer focus and hence a very loud and bullish indicator.   Brazilian news is according to what we know so far is generic based but we have no idea what the new ...more  
Comment by Olaf123 on Dec 23, 2023 8:21pm
Cancer drug made by Synaptogenix? They were already working with Bryostatin-1. "On behalf of Cannasoul, we are very excited to partner with Synaptogenix and believe that Synaptogenix's expertise in pharmaceutical development will enable us to advance development and commercialization of Cannasoul's current intellectual property. They came up with something independently ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities